{"id":"at-301","_chembl":null,"_dailymed":null,"_scrapedAt":"2026-03-28T05:38:38.072Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_claudeStub":{"ts":1779123640,"model":"claude-sonnet-4-5-20250929"},"description":"AT-301 is an investigational therapeutic developed by Medigen Biotechnology Corporation currently in Phase 1 clinical trials. Limited public information is available regarding its molecular target, mechanism of action, or specific therapeutic indications at this early stage of development.","indications":{"approved":[{"status":"investigational","condition":null,"patientPopulation":null}]},"trialDetails":[{"nctId":"NCT04519788","phase":"PHASE1","title":"AT-301 Nasal Spray in Healthy Adults","status":"COMPLETED","sponsor":"Atossa Therapeutics, Inc.","startDate":"2020-08-07","conditions":"Healthy","enrollment":32},{"nctId":"NCT01675284","phase":"PHASE1","title":"A Phase I Study to Evaluate the Safety, Reactogenicity, and Humoral Immune Responses to an Inactivated H5N1 Influenza Vaccine","status":"COMPLETED","sponsor":"Medigen Biotechnology Corporation","startDate":"2012-08","conditions":"Bird Flu, Avian Influenza, Influenza A(H5N1)","enrollment":36}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"AT-301","genericName":"AT-301","companyName":"Medigen Biotechnology Corporation","companyId":"medigen-biotechnology-corporation","modality":"Biologic","firstApprovalDate":"","aiSummary":"AT-301 is a nasal spray being studied in a clinical trial for its safety in healthy adults. The study also involves investigating AT-301 for its potential use in treating Bird Flu, Avian Influenza, and Influenza A(H5N1).","enrichmentLevel":2,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}